Post written by Pichamol Jirapinyo, MD, MPH, from the Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. The current treatment for nonalcoholic steatohepatitis (NASH) remains limited to weight loss via lifestyle modification. While bariatric surgery can be considered in otherwise eligible patients who suffer from obesity with concomitant NASH, less than 2% of …
Tag: cirrhosis
Efficacy and safety of ESD between cirrhosis and noncirrhosis patients
Post written by Ji Yong Ahn, MD, and Young Kwon Choi, MD, from the Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. We compared the clinical outcomes of ESD for gastric neoplasms between cirrhosis and noncirrhosis patients. In addition, we analyzed the Child–Pugh classification status before and after ESD …
Continue reading Efficacy and safety of ESD between cirrhosis and noncirrhosis patients
Therapeutic ERCP in patients with cirrhosis
Ali Siddiqui, MD, from the Division of Gastroenterology and Hepatology, Jefferson University School of Medicine, in Philadelphia, Pennsylvania, USA discusses this Original Article, "Efficacy and safety of therapeutic ERCP in patients with cirrhosis: a large multicenter study." We performed a multicenter study to evaluate outcomes, efficacy, and safety of ERCP in patients with cirrhosis. We …
Continue reading Therapeutic ERCP in patients with cirrhosis
endoscopedia.com 